ArticleHematology reports2021

Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.

Panayotis Kaloyannidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.